| ADTX 0.0127 -2.31% | SOXS 4.72 -5.03% | SPCX 160.95 19.22% | DFNS 0.233 -9.20% | BITO 8.65 0.12% | RUBI 0.4676 -24.62% | TZA 4.16 -2.58% | CAST 1.55 140.68% | AAL 14.98 2.25% | INTC 124.57 6.51% | SPCE 3.91 -31.76% | SHFS 0.276 16.46% | SRXH 0.148 17.65% | NOK 14.795 5.00% | NVDA 205.19 0.16% | BYAH 1.47 40.00% | SPDN 8.81 -0.45% | TQQQ 77.52 1.99% | TSLL 13.59 3.58% | PAVS 0.208 -28.28% | CPOP 0.195 -81.43% | SMCI 30.46 -4.72% | CUPR 3.97 64.73% | VSME 1.69 52.25% | YYGH 0.119 -3.25% | SQQQ 40.04 -1.93% | RKLB 102.39 -10.79% | TSLA 406.43 1.82% | NVD 5.02 -0.40% | WOK 0.0753 -17.70% | SPY 741.75 0.54% | ASTS 82.41 -15.53% | KEEL 5.59 1.27% | ONDS 9.33 -5.09% | SPYM 87.06 0.25% | AMZN 238.55 -1.23% | XLF 53.34 1.37% | SATS 114.08 -10.97% | QQQ 721.34 0.59% | SOFI 16.58 -0.54% | PLUG 2.76 -2.47% | SOXL 234.68 4.77% | GRAB 3.3 -1.49% | DRIP 4.74 -2.47% | AMC 2.34 2.63% | IREN 59.77 5.40% | HKIT 0.5025 -10.11% | RKLZ 3.01 21.37% | RZLV 2.68 5.93% | MARA 14.08 3.45%

Freshpet Shares Gain 9% as Q3 Profit Smashes Estimates, Guidance Tightened

Freshpet Inc. (NASDAQ: FRPT) reported third-quarter earnings that far exceeded Wall Street expectations, sending shares up more than 9% in intra-day trading on Monday.

The company posted adjusted earnings of $1.86 per share, dramatically surpassing analyst estimates of $0.43. Revenue rose 14% year-over-year to $288.8 million, beating the consensus forecast of $284.22 million. Growth was driven by a 12.9% increase in volume and a 1.1% favorable price/mix effect.

Freshpet achieved positive free cash flow during the quarter for the first time and now expects to remain free cash flow positive for the full fiscal year 2025, one year earlier than anticipated. Adjusted EBITDA climbed to $54.6 million from $43.5 million in the same quarter last year.

The company updated its full-year 2025 guidance, projecting net sales growth of approximately 13%, down slightly from the prior range of 13% to 16%. It also narrowed its adjusted EBITDA outlook to between $190 million and $195 million from the previous $190 million to $210 million range. Capital expenditure guidance was reduced to about $140 million from $175 million.

Published on: November 3, 2025